文献速递甲状腺疾病

意大利单中心研究:甲状腺微小乳头状癌主动监测可行且安全

Active Surveillance in Papillary Thyroid Microcarcinomas is Feasible and Safe: Experience at a Single Italian Center.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

该前瞻性观察研究纳入93例符合条件的甲状腺微小乳头状癌患者,中位随访19个月(范围6-54个月),仅3%出现疾病进展需手术,另20%虽无进展仍选择手术,所有手术患者对初始治疗反应极佳。结论认为在意大利医疗背景下,主动监测是健康mPTC患者替代立即手术的可行且安全选择。

要点

  • 中位随访19个月,仅3%的mPTC患者出现疾病进展。
  • 20%患者虽无进展证据仍选择转为手术。
  • 所有手术患者对初始治疗反应极佳。

核心结论

  • 在意大利医疗背景下,主动监测是健康mPTC患者替代立即手术的可行且安全选择。
  • 仅3%的mPTC患者在中位随访19个月内出现疾病进展,且短期随访中手术后结局极佳。

研究设计与样本

  • 2014年启动的前瞻性观察研究,单中心意大利研究。
  • 纳入93例患者,为单个Thy4或Thy5甲状腺结节、最大直径≤1.3 cm、颈部超声无可疑侧颈淋巴结。
  • 185例符合条件者中50.3%(93/185)入组观察方案,其余选择手术并被排除。

主要发现

  • 3例(3/93,3%)出现临床进展需手术。
  • 另19例(19/93,20%)虽无疾病进展证据仍决定转为手术。
  • 所有手术患者尽管手术延迟,对初始治疗均反应极佳。

关键数值与推荐

  • 入组标准:单个Thy4或Thy5甲状腺结节,最大直径≤1.3 cm,颈部超声无可疑侧颈淋巴结。
  • 随访方案:每6至12个月进行颈部超声。
  • 疾病进展定义:随访期间出现异常淋巴结或结节增大。
  • 中位随访19个月(范围6-54个月)。

临床怎么用

  • 对符合条件的健康mPTC患者,可考虑主动监测作为立即手术的替代方案。
  • 主动监测期间每6至12个月行颈部超声,发现异常淋巴结或结节增大时转手术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The dramatic rise in the incidence of thyroid cancer over the last 30 years is largely attributable to the increasing diagnosis of papillary microcarcinomas (mPTCs). Current guidelines endorse an observational management approach in properly selected cases. OBJECTIVE: To evaluate the feasibility of active surveillance in mPTC in Italy, its impact on real life, and to identify risk factors of progression. DESIGN AND SETTING: In 2014 we started a prospective-observational study of active surveillance in mPTC patients. PATIENTS: Included patients demonstrated a single Thy4 or Thy5 thyroid nodule, with largest diameter ≤1.3 cm, and no suspicious laterocervical lymph nodes by neck ultrasonography. Of 185 eligible subjects, 50.3% (93/185) enrolled in the observational management protocol while the others opted for surgery and were excluded from this analysis. INTERVENTION: Enrolled patients were followed with neck ultrasound at 6- to 12-month intervals. Disease progression was defined as the appearance of abnormal lymph nodes or nodule enlargement during follow-up. In these cases, patients were directed to surgery. RESULTS: Three patients (3/93, 3%) showed clinical progression and required surgery. Another 19 patients (19/93, 20%) decided to transition to surgical intervention even though there was no evidence of disease progression. All operated patients had excellent response to initial treatment despite the delayed surgery. CONCLUSIONS: Within an Italian medical context, active surveillance appears to be a feasible and safe alternative to immediate surgery in healthy mPTC patients. Only 3% of mPTC demonstrated disease progression during a median follow-up of 19 months (range 6-54) and importantly demonstrated excellent outcomes after surgical intervention in a short-term follow-up.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Molinaro E, Campopiano MC, Pieruzzi L, et al. Active Surveillance in Papillary Thyroid Microcarcinomas is Feasible and Safe: Experience at a Single Italian Center. J Clin Endocrinol Metab. 2020. PMID: 31652318. doi:10.1210/clinem/dgz113

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。